Company news
ENDRA Life Sciences Inc. news in 2022
ENDRA Life Sciences Inc.'s news releases, calls and decks from 2022, newest first.
ENDRA Life Sciences Announces 1-for-20 Reverse Stock Split
December 4, 2022
ENDRA Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update
November 13, 2022
ENDRA Life Sciences to Report Third Quarter 2022 Financial Results on November 14, 2022
November 8, 2022
ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of Two U.S. Patents
October 24, 2022
ENDRA Life Sciences Plans to Submit De Novo Request to U.S. FDA for its TAEUS® System in Coming Weeks
September 28, 2022
ENDRA Life Sciences Announces Issuance of 8th European Patent for its TAEUS® System
August 23, 2022
ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update
August 14, 2022
ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022
August 3, 2022
ENDRA Life Sciences Awarded Three Additional U.S. Patents for Cloud-enabled Connectivity of Medical Devices
August 1, 2022
ENDRA Life Sciences Awarded Two Additional Chinese Patents for its TAEUS® System
July 10, 2022
ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of 28th U.S. Patent
June 27, 2022
ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with Issuance of 27th U.S. Patent
May 24, 2022
ENDRA Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update
May 11, 2022
ENDRA Life Sciences Issued Additional U.S. and Chinese Patents for its TAEUS® System
May 9, 2022
ENDRA Life Sciences to Report First Quarter 2022 Financial Results on May 12, 2022
May 1, 2022
ENDRA Life Sciences Raises $8.7 Million in Gross Proceeds Through its At-The-Market Facility
April 20, 2022
ENDRA Life Sciences Achieves Key Quality Management System Certification
March 30, 2022
ENDRA Life Sciences Strengthens TAEUS® System Global Intellectual Property Protection with Issuance of 10th and 11th Chinese Patents
March 29, 2022
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
March 29, 2022
ENDRA Life Sciences to Report Fourth Quarter 2021 Financial Results on March 30, 2022
March 21, 2022
ENDRA Life Sciences Strengthens TAEUS® System Intellectual Property with Issuance of 24th U.S. Patent
March 7, 2022
ENDRA Life Sciences Strengthens TAEUS® System Global Intellectual Property Portfolio with Issuance of 6th and 7th European Patents
February 10, 2022
ENDRA Life Sciences Provides Update on U.S. Regulatory Strategy for its TAEUS® System
February 8, 2022
ENDRA Life Sciences Expands into China with Shanghai General Hospital Partnership
January 23, 2022
Calls in 2022
- ENDRA Life Sciences (NASDAQ:NDRA) Q3 2022 Earnings Call
Nov 14, 2022
Transcript - ENDRA Life Sciences (NASDAQ:NDRA) Q2 2022 Earnings Call
Aug 15, 2022
Transcript - ENDRA Life Sciences (NASDAQ:NDRA) Q1 2022 Earnings Call
May 12, 2022
Transcript - ENDRA Life Sciences (NASDAQ:NDRA) Q4 2021 Earnings Call
Mar 30, 2022
Transcript
Decks in 2022
- Investor Presentation (January 2022)
Investor deck · 19 slides · Jan 7, 2022